Table 5 Neurological outcomes–groupwise comparison between S100B T2 ≥ 0.23 and S100B T2 < 0.23
Neurological outcomes | All n = 312 | S100B T2 ≥ 0.23 n = 108 | S100B T2 < 0.23 n = 204 | p | Missing |
|---|---|---|---|---|---|
Neurological injury | 83 (26.6) | 50 (46.3) | 33 (16.2) | < 0.01 | 0 (0) |
Postoperative stroke | 65 (20.9) | 35 (32.7) | 30 (14.7) | < 0.01 | 1 (0.) |
Postoperative coma | 29 (9.3) | 24 (22.4) | 5 (2.5) | < 0.01 | 1 (0.3) |
Transient cerebral event | 5 (1.6) | 0 (0) | 5 (2.5) | 0.17 | 1 (0.3) |
Ventilation > 48 h | 141 (45.3) | 68 (63.0) | 73 (36.0) | < 0.01 | 1 (0.3) |
Renal replacement therapy | 34 (10.9) | 22 (20.4) | 12 (5.9) | < 0.01 | 0 (0) |
Multiple organ failure | 6 (3.0) | 5 (8.9) | 1 (0.7) | < 0.01 | 111 (35.6) |
30-day mortality | 24 (7.7) | 17 (15.7) | 7 (3.5) | < 0.01 | 2 (0.6) |
In-hospital mortality | 28 (9.0) | 19 (17.6) | 9 (4.4) | < 0.01 | 1 (0.3) |